Here is the synopsis of our sample research paper on Pfizer Pharmaceuticals Financial Analysis. Have the paper e-mailed to you 24/7/365.
Essay / Research Paper Abstract
A 10 page paper that provides a fiscal analysis of Pfizer Inc. This is the largest pharmaceutical company in the world and the one that sells more 'blockbuster' drugs than any other company. The company has 10 drugs that each generate more than $1 billion in sales every year. This paper provides a brief overview of the company and then launches into presenting fiscal data regarding the company and its competitors. These data include various ratios concerning performance, such as ROA, ROE, P/E, and other valuation data, selected data from each the company's income statement and balance statement (comparing the last three years). Stock performance is also reported and discussed. Significant amounts of data are included. 7 Tables are included. Bibliography lists 11 sources.
Page Count:
10 pages (~225 words per page)
File: MM12_PGpfizr.rtf
Buy This Term Paper »
Unformatted sample text from the term paper:
is increasingly divided into two camps: Pfizer and everyone else" (Harris, 2003, p. C1). Pfizer produces and sells more of the "blockbuster" drugs than any of its competitors; these include
"Lipitor, a cholesterol-lowering medicine; Zoloft, an antidepressant; Viagra, for impotence; Norvasc, a hypertension pill; and Celebrex, for arthritis" (Morningstar.com, 2003). Harris comments that Pfizer "has 10 products with more than
$1 billion each in sales. It owns the rights to 8 of the 25 largest-selling drugs" and "165 million people worldwide take its medicines" (Harris, 2003, p. C1). In terms
of market capitalization, only General Electric is larger than Pfizer (Harris, 2003). Ten percent of the companys total revenues are derived from popular consumer healthcare products, such as Nicorette smoking-cessation
products, Visine eye drops and animal medicines (Morningstar.com, 2003). The following table illustrates how much larger Pfizer is compared to its three highest competitors. Table 1: Sales Comparison (Mkt
Cap as of 10-10-03. Sales TTM through most recent quarter-end) Mkt Cap $Mil Sales $Mil Industry Average 11,105 3,115 Pfizer 239,426.0 35,848 Johnson & Johnson 146,145 38,635 Merck
110,778 53,481 Novartis AG ADR 100,137 20,692 (Source: Morningstar.com, Stock Grades, 2003). Besides prescription drugs, Pfizer also produces a large assortment of over-the-counter remedies, such as Sudafed and
Benadryl (Koenig 2003). Other pet care products include Revolution, which is an antiparasitic substance (Koenig 2003). Pfizers subsidiaries include Goedecke, Warner-Lambert and Parke-Davis (Koenig 2003). Two-thirds of the companys
revenues come from the market in the United States (Koenig 2003). In April 2003, Pfizer Inc added another company to its stable; Pfizer acquired Pharmacia Corp for a publicized $57
billion (Morse, 2003). The acquisition of Pharmacia along with other smaller acquisitions left Pfizer showing a loss of 48 cents per share (Morse, 2003). This compared to a gain of
...